White, Harvey D.; Steg, Ph. Gabriel; Szarek, Michael; Bhatt, Deepak L.; Bittner, Vera A.; Diaz, Rafael; Edelberg, Jay M.; Erglis, Andrejs; Goodman, Shaun G.; Hanotin, Corinne; Harrington, Robert A.; Jukema, J Wouter; Lopes, Renato D.; Mahaffey, Kenneth W.; Moryusef, Angele; Pordy, Robert; Roe, Matthew T.; Sritara, Piyamitr; Tricoci, Pierluigi; Zeiher, Andreas M.; Schwartz, Gregory G.; Peršić, ViktorMore authors...
Cite this document
White, H. D., Steg, P. G., Szarek, M., Bhatt, D. L., Bittner, V. A., Diaz, R. ... Peršić, V. (2019). Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. European Heart Journal, 40. (33), 2801-2809. doi: 10.1093/eurheartj/ehz299
White, Harvey D., et al. "Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial." European Heart Journal, vol. 40, no. 33, 2019, pp. 2801-2809. https://doi.org/10.1093/eurheartj/ehz299
White, Harvey D., Ph. Gabriel Steg, Michael Szarek, Deepak L. Bhatt, Vera A. Bittner, Rafael Diaz, Jay M. Edelberg, et al. "Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial." European Heart Journal 40, no. 33 (2019): 2801-2809. https://doi.org/10.1093/eurheartj/ehz299
White, H. D., et al. (2019) 'Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial', European Heart Journal, 40(33), pp. 2801-2809. doi: 10.1093/eurheartj/ehz299
White HD, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, and sur.. Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial. European Heart Journal [Internet]. 2019 September 01 [cited 2025 February 19];40(33):2801-2809. doi: 10.1093/eurheartj/ehz299
H. D. White, et al., "Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial", European Heart Journal, vol. 40, no. 33, pp. 2801-2809, September 2019. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:432371. [Accessed: 19 February 2025]